8-K
filed August 10, 2023, 7:59 PM ET
ticker NOTV
CIK 0000720154
earnings
confidence high
sentiment negative
materiality 0.75
Inotiv Q3 revenue $157.5M (-8.8% YoY); cuts FY2023 guidance to at least $570M
Inotiv, Inc.
2023-Q3 EPS reported
-$3.72
revenue$431,685,000
- Q3 revenue $157.5M, down 8.8% YoY; net income $0.4M vs loss $(3.6M) in Q3 FY2022.
- Adjusted EBITDA $30.5M (19.4% of revenue) vs $37.0M (21.4%) prior year.
- FY2023 guidance cut: revenue at least $570M (from $580M), adjusted EBITDA at least $60M (from $70M).
- DSA backlog $149.1M, net book-to-bill 1.08x; YTD RMS goodwill impairment $66.4M.
- Cash $22.2M; total debt $375.6M; no borrowings on $15M revolver; in compliance with debt covenants.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.91
Inotiv, Inc. reported YTD FY 2023 (nine months ended June 30, 2023) results: revenue $431.7 million, net income $(96.2) million.
- Period
- YTD FY 2023 (nine months ended June 30, 2023)
- Revenue
- $431.7 million
- Net income
- $(96.2) million
- Result
- reported results
Exact text from the filing
Revenue grew to $431.7 million in YTD FY 2023
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.91
Inotiv, Inc. reported Q3 FY 2023 (three months ended June 30, 2023) results: revenue $157.5 million, net income $0.4 million.
- Period
- Q3 FY 2023 (three months ended June 30, 2023)
- Revenue
- $157.5 million
- Net income
- $0.4 million
- Result
- reported results
Exact text from the filing
Financial Highlights Q3 FY 2023 Highlights • Revenue was $157.5 million in Q3 FY 2023 as compared to $172.7 million during the three months ended June 30, 2022 (“Q3 FY 2022”), driven by a $2.4 million, or 5.0%, decrease in Discovery and Safety Assessment (“DSA”) revenue and a $12.7 million, or 10.3%, decrease in Research Models and Services (“RMS”) revenue.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.